SCHEMBL6985246

SCHEMBL6985246

COC(=O)c1ccc2c(c1)CCCN2C(=O)CCc1ccc(C#N)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.51
PDK1 Q15118 1/20 0.51
PDK2 Q15119 1/20 0.51
PDK3 Q15120 1/20 0.51
PDK4 Q16654 1/20 0.51
HDAC1 Q13547 2/20 0.46
HDAC8 Q9BY41 2/20 0.46
HDAC6 Q9UBN7 2/20 0.46
MAPT P10636 4/20 0.45
NPC1 O15118 1/20 0.45
MAPK1 P28482 1/20 0.45
RAB9A P51151 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
ALDH1A1 P00352 4/20 0.43
ABCB1 P08183 1/20 0.43
GAA P10253 1/20 0.43
ABCG2 Q9UNQ0 1/20 0.43
KDM4E B2RXH2 1/20 0.42
IDO1 P14902 1/20 0.42
KCNH2 Q12809 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6986538 0.84 TP53 (0.49) TP53PDK1PDK2PDK3PDK4
SCHEMBL6977395 0.84 TP53 (0.46) TP53HDAC1HDAC8HDAC6MAPT
SCHEMBL6981826 0.84 PDK1 (0.52) TP53PDK1PDK2PDK3PDK4
SCHEMBL6986432 0.84 TP53 (0.48) TP53HDAC1HDAC8HDAC6MAPT
SCHEMBL6977738 0.83 TP53 (0.51) TP53HDAC1HDAC8HDAC6MAPT
SCHEMBL6983536 0.83 TP53 (0.43) TP53HDAC1HDAC8HDAC6MAPT
SCHEMBL6985141 0.83 AVPR2 (0.47) TP53PDK2HDAC1HDAC8HDAC6
SCHEMBL6979722 0.82 TP53 (0.48) TP53PDK1PDK2PDK3PDK4
SCHEMBL7410530 0.82 TP53 (0.45) TP53PDK1PDK2PDK3PDK4
SCHEMBL6984356 0.82 SMN1; SMN2 (0.53) TP53HDAC1HDAC8HDAC6MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed
EP-0991624-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT Boehringer Ingelheim Pharma KG (DE) 2000-04-12 EP disclosed
WO-1999000371-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-01-07 WO disclosed